Related Experiment Video
Updated: May 6, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Restenosis after infrapopliteal angioplasty - clinical importance, study update and further directions
Frederic Baumann1, Nicolas Diehm
1Department of Clinical and Interventional Angiology, Swiss Cardiovascular Center, Inselspital, University Hospital of Bern, Switzerland.
Insights
Critical limb ischemia (CLI) patients face high mortality from peripheral arterial disease (PAD). Understanding tibial restenosis pathophysiology and developing new strategies are crucial for improving outcomes in these challenging cases.
Area of Science:
- Vascular Medicine
- Interventional Cardiology
- Regenerative Medicine
Background:
- Critical limb ischemia (CLI) is the most severe form of peripheral arterial disease (PAD), associated with high mortality rates.
- Infrapopliteal arterial disease is common in CLI patients, posing challenges for endovascular revascularization.
- Restenosis after tibial angioplasty significantly impacts clinical outcomes, affecting over two-thirds of CLI patients.
Purpose of the Study:
- To provide an updated review of the pathophysiology of tibial restenosis.
- To discuss current and emerging antirestenosis strategies for tibial angioplasty in CLI patients.
Main Methods:
- Literature review of studies on tibial restenosis in critical limb ischemia.
- Analysis of current clinical trials investigating antirestenosis concepts.
- Synthesis of knowledge from coronary artery research applied to tibial arteries.
Main Results:
- Tibial patency is essential for optimal clinical outcomes in CLI patients post-angioplasty.
- The precise pathophysiological mechanisms of tibial restenosis are not fully understood.
- Multiple strategies are under investigation to mitigate tibial restenosis.
Conclusions:
- Further research into the specific pathophysiology of tibial restenosis is warranted.
- Developing effective antirestenosis strategies is critical for improving CLI patient prognosis.
- Optimizing tibial angioplasty outcomes requires a comprehensive understanding of restenosis mechanisms.
Abstract:
Patients with critical limb ischemia (CLI) represent the most severe form of peripheral arterial disease (PAD) and exhibit high mortality rates. Frequently, PAD in CLI patients involves the infrapopliteal arterial segment challenging endovascular revascularization strategies. Restenosis remains the major drawback of tibial angioplasty encountered in more than two thirds of CLI patients undergoing tibial revascularization. In contrast to earlier observations, tibial patency was recently shown to be essential to attain an optimal clinical outcome in CLI patients subsequent to tibial angioplasty. The exact pathopyhsiological mechanisms of tibial restenosis remains unclear. To date, most of our knowledge on tibial restenosis and its pathophysiology is derived from coronary arteries, based on the similarity of coronary arteries to tibial artery morphology. Nervertheless, multiple antirestenosis concepts are investigated within clinical trials to reduce tibial restenosis.Purpose of the present manuscript is to provide a current update on the pathophysiology of tibial restenosis and potential antirestenosis strategies.
More Related Videos
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
06:53A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application
Published on: July 9, 2020
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Coronary Artery Disease V: Interprofessional Care
Atherosclerosis III: Management
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease I: Introduction